Lyst mutation in mice recapitulates iris defects of human exfoliation syndrome

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 3, 2009, Pages 1205-1214

  Trantow, Colleen M ^a   Mao, Mao ^a   Petersen, Greg E ^a   Alward, Erin M ^a   Alward, Wallace L M ^a   Fingert, John H ^a   Anderson, Michael G ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOLEUCINE; LYST PROTEIN, MOUSE; PROTEIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXFOLIATION SYNDROME; FEMALE; GENE; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; LYST GENE; MALE; MOLECULAR GENETICS; MOUSE; NONHUMAN; OPTIC NERVE LESION; PIGMENT EPITHELIUM; PIGMENTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SLIT LAMP; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; IRIS DISEASE; MUTATION; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; EXFOLIATION SYNDROME; HUMANS; IRIS DISEASES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; PIGMENT EPITHELIUM OF EYE; PROTEINS;

EID: 62649089753     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2791     Document Type: Article

References (61)

1. Lahners W, Samuelson TW. Pseudoexfoliative glaucoma. In: Yanoff M, Duker JS, eds. Ophthalmology. St Louis: Mosby; 2004:1499-1503.
2. Ritch R, Schlotzer-Schrehardt U. Exfoliation (pseudoexfoliation) syndrome: toward a new understanding. Proceedings of the First International Think Tank. Acta Ophthalmol Scand. 2001;79:213-217.
3. Ritch R, Schlotzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265-315.
4. Schlotzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006;141:921-937.
5. Vesti E, Kivel AT. Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res. 2000;19:345-368.
6. Yanoff M, Fine BS. Lens. Ocular Pathology. St. Louis: Mosby; 2002:339-370.
7. Ritch R. A unification hypothesis of pigment dispersion syndrome. Trans Am Ophthalmol Soc. 1996;94:381-405; discussion 405-409.
8. Davanger M. On the ultrastructure and the formation of pseudoexfoliation material. Acta Ophthalmol (Copenh). 1980;58:520-527.
9. Schlotzer-Schrehardt U, von der Mark K, Sakai LY, Naumann GO. Increased extracellular deposition of fibrillin-containing fibrils in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 1997;38:970-984.
10. Schlotzer-Schrehardt U, Dorfler S, Naumann GO. Immunohistochemical localization of basement membrane components in pseudoexfoliation material of the lens capsule. Curr Eye Res. 1992;11:343-355.
11. Schlotzer-Schrehardt U, Zenkel M, Kuchle M, Sakai LY, Naumann GO. Role of transforming growth factor-beta 1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res. 2001;73:765-780.
12. Gottfredsdottir MS, Sverrisson T, Musch DC, Stefansson E. Chronic open-angle glaucoma and associated ophthalmic findings in monozygotic twins and their spouses in Iceland. J Glaucoma. 1999;8:134-139.
13. Allingham RR, Loftsdottir M, Gottfredsdottir MS, et al. Pseudoexfoliation syndrome in Icelandic families. Br J Ophthalmol. 2001;85:702-707.
14. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317:1397-1400.
15. Fingert JH, Alward WL, Kwon YH, et al. LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States. Am J Ophthalmol. 2007;144:974-975.
16. Hewitt AW, Sharma S, Burdon KP, et al. Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet. 2008;17:710-716.
17. Hayashi H, Gotoh N, Ueda Y, Nakanishi H, Yoshimura N. Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population. Am J Ophthalmol. 2008;145:582-585.
18. Fan BJ, Pasquale L, Grosskreutz CL, et al. DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity. BMC Med Genet. 2008;9:5.
19. Yang X, Zabriskie NA, Hau VS, et al. Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort. Cell Cycle. 2008;7:521-524.
20. Challa P, Schmidt S, Liu Y, et al. Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma. Mol Vis. 2008;14:146-149.
21. Ramprasad VL, George R, Soumittra N, Sharmila F, Vijaya L, Kumaramanickavel G. Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India. Mol Vis. 2008;14:318-322.
22. Pasutto F, Krumbiegel M, Mardin CY, et al. Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1459-1463.
23. Mossbock G, Renner W, Faschinger C, Schmut O, Wedrich A, Weger M. Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population. Mol Vis. 2008;14:857-861.
24. Mori K, Imai K, Matsuda A, et al. LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population. Mol Vis. 2008;14:1037-1040.
25. Alward WL, Munden PM, Verdick RE, Perell HR, Thompson HS. Use of infrared videography to detect and record iris transillumination defects. Arch Ophthalmol. 1990;108:748-750.
26. Smith RS, Korb D, John SW. A goniolens for clinical monitoring of the mouse iridocorneal angle and optic nerve. Mol Vis. 2002;8:26-31.
27. Kim CY, Kuehn MH, Anderson MG, Kwon YH. Intraocular pressure measurement in mice: a comparison between Goldmann and rebound tonometry. Eye. 2007;21:1202-1209.
28. Smith R, Zabaleta A, John S, et al. General and special histopathology. In: Smith RS, ed. Systemic Evaluation of the Mouse Eye. Boca Raton: CRC Press; 2002:265-297.
29. Anderson MG, Libby RT, Gould DB, Smith RS, John SW. High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma. Proc Natl Acad Sci U S A. 2005;102:4566-4571.
30. Libby RT, Li Y, Savinova OV, et al. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005;1:17-26.
31. Collier LL, Bryan GM, Prieur DJ. Ocular manifestations of the Chediak-Higashi syndrome in four species of animals. J Am Vet Med Assoc. 1979;175:587-590.
32. Collier LL, Prieur DJ, King EJ. Ocular melanin pigmentation anomalies in cats, cattle, mink, and mice with Chediak-Higashi syndrome: histologic observations. Curr Eye Res. 1984;3:1241-1251.
33. Robison WG Jr, Kuwabara T. Light-induced alterations of retinal pigment epithelium in black, albino, and beige mice. Exp Eye Res. 1976;22:549-557.
34. Robison WG Jr, Kuwabara T, Cogan DG. Lysosomes and melanin granules of the retinal pigment epithelium in a mouse model of the Chediak-Higashi syndrome. Invest Ophthalmol. 1975;14:312-317.
35. Runkel F, Bussow H, Seburn KL, et al. Grey, a novel mutation in the murine Lyst gene, causes the beige phenotype by skipping of exon 25. Mamm Genome. 2006;17:203-210.
36. Valenzuela R, Morningstar WA. The ocular pigmentary disturbance of human Chediak-Higashi syndrome: a comparative light- and electron-microscopic study and review of the literature. Am J Clin Pathol. 1981;75:591-596.
37. Anderson MG, Hawes NL, Trantow CM, Chang B, John SWM. Iris phenotypes and pigment dispersion caused by genes influencing pigmentation. Pigment Cell Melanoma Res. 2008;21:565-578.
38. Anderson MG, Smith RS, Hawes NL, et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet. 2002;30:81-85.
39. Roberts DK, Chaglasian MA, Meetz RE. Iris transillumination defects in the pigment dispersion syndrome as detected with infrared videography: a comparison between a group of blacks and a group of nonblacks. Optom Vis Sci. 1999;76:544-549.
40. Foos RY. Iris in pseudoexfoliation. Ophthalmology. 1991;98:1486-1487.
41. Repo LP, Terasvirta ME, Tuovinen EJ. Generalized peripheral iris transluminance in the pseudoexfoliation syndrome. Ophthalmology. 1990;97:1027-1029.
42. Asano N, Schlotzer-Schrehardt U, Naumann GO. A histopathologic study of iris changes in pseudoexfoliation syndrome. Ophthalmology. 1995;102:1279-1290.
43. Eagle RC Jr, Font RL, Fine BS. The basement membrane exfoliation syndrome. Arch Ophthalmol. 1979;97:510-515.
44. Smith RS. The anterior segment and ocular adnexae. In: Smith RS, ed. Systemic Evaluation of the Mouse Eye. Boca Raton: CRC Press; 2002:366.
45. Smith RS. Choroid, lens, and vitreous. In: Smith RS, ed. Systemic Evaluation of the Mouse Eye. Boca Raton: CRC Press; 2002:161-193.
46. Lane PW. Bg〈2J〉 - beige-2J. Mouse News Lett. 1962;26:35.
47. Smith TF, Gaitatzes C, Saxena K, Neer EJ. The WD repeat: a common architecture for diverse functions. Trends Biochem Sci. 1999;24:181-185.
48. Bax DV, Mahalingam Y, Cain S, et al. Cell adhesion to fibrillin-1: identification of an Arg-Gly-Asp-dependent synergy region and a heparin-binding site that regulates focal adhesion formation. J Cell Sci. 2007;120:1383-1392.
49. Chu ML, Tsuda T. Fibulins in development and heritable disease. Birth Defects Res C Embryo Today. 2004;72:25-36.
50. Kielty CM. Elastic fibres in health and disease. Expert Rev Mol Med. 2006;8:1-23.
51. Wagenseil JE, Mecham RP. New insights into elastic fiber assembly. Birth Defects Res C Embryo Today. 2007;81:229-240.
52. Tchernev VT, Mansfield TA, Giot L, et al. The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins. Mol Med. 2002;8:56-64.
53. Barbosa MD, Nguyen QA, Tchernev VT, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature. 1996;382:262-265.
54. Kaplan J, De Domenico I, Ward DM. Chediak-Higashi syndrome. Curr Opin Hematol. 2008;15:22-29.
55. Shiflett SL, Kaplan J, Ward DM. Chediak-Higashi syndrome: a rare disorder of lysosomes and lysosome related organelles. Pigment Cell Res. 2002;15:251-257.
56. Ward DM, Shiflett SL, Huynh D, Vaughn MB, Prestwich G, Kaplan J. Use of expression constructs to dissect the functional domains of the CHS/beige protein: identification of multiple phenotypes. Traffic. 2003;4:403-415.
57. Perou CM, Leslie JD, Green W, Li L, Ward DM, Kaplan J. The Beige/Chediak-Higashi syndrome gene encodes a widely expressed cytosolic protein. J Biol Chem. 1997;272:29790-29794.
58. Karim MA, Suzuki K, Fukai K, et al. Apparent genotype-phenotype correlation in childhood, adolescent, and adult Chediak-Higashi syndrome. Am J Med Genet. 2002;108:16-22.
59. Uyama E, Hirano T, Ito K, et al. Adult Chediak-Higashi syndrome presenting as parkinsonism and dementia. Acta Neurol Scand. 1994;89:175-183.
60. Perou CM, Justice MJ, Pryor RJ, Kaplan J. Complementation of the beige mutation in cultured cells by episomally replicating murine yeast artificial chromosomes. Proc Natl Acad Sci U S A. 1996;93:5905-5909.
61. Rudelius M, Osanger A, Kohlmann S, et al. A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive Purkinje cell degeneration. Acta Neuropathol (Berl). 2006;112:267-276.